skip navigation

Skip Nav

Drugs News

FDA Updates Stribild Labeling

Date: August 28, 2014

Source: Food and Drug Administration (FDA)

http://content.govdelivery.com/accounts/USFDA/bulletins/ccdd8d/

FDA Approves New Fixed-Dose Combination Drug, Triumeq (Abacavir, Dolutegravir, Lamivudine)

Date: August 22, 2014

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/1487/fda-approves-new-fixed-dose-combination-drug-triumeq-(abacavir-dolutegravir-lamivudine)

FDA Updates Etravirine Labeling

Date: August 20, 2014

Source: Food and Drug Administration (FDA)

http://content.govdelivery.com/accounts/USFDA/bulletins/cb64e0/

FDA Updates Complera Labeling

Date: June 6, 2014

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm400180.htm

FDA Approves New Dosage Form and Label Changes for Atazanavir

Date: June 5, 2014

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm400161.htm

New CDC Guidelines Recommend Daily HIV Prevention Pill for Those at Substantial Risk

Date: May 14, 2014

Source: Centers for Disease Control and Prevention (CDC)

Author: National Center for HIV, STD, and TB Prevention (NCHHSTP)

http://aidsinfo.nih.gov/news/1451/new-cdc-guidelines-recommend-daily-hiv-prevention-pill-for-those-at-substantial-risk

FDA Updates Dolutegravir Labeling

Date: May 12, 2014

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm397765.htm

FDA Updates Rilpivirine Labeling

Date: May 1, 2014

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm395936.htm

Updated “Drugs That Fight HIV-1” Brochure Available

Date: April 22, 2014

Source: AIDSinfo

http://aidsinfo.nih.gov/contentfiles/upload/HIV_Pill_Brochure.pdf

FDA Updates Raltegravir Labeling

Date: April 8, 2014

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm392852.htm

FDA Updates Darunavir Labeling

Date: April 7, 2014

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm392741.htm

FDA Approves Generic Formulation of Lamivudine and Zidovudine Tablets

Date: February 3, 2014

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm384582.htm

FDA Approves Oral Suspension Form of Raltegravir

Date: December 20, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm379632.htm

FDA Updates Complera Labeling with New Indication, Adverse Reactions, and Clinical Trial Data

Date: December 13, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm379067.htm

FDA Reopening of Comment Period: HIV-Focused Drug Development and HIV Cure Research

Date: August 20, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm365763.htm

Antiretroviral Drugs May Protect Against Puberty Delays in HIV-Infected Children

Date: August 15, 2013

Source: National Institutes of Health (NIH) - no specific institute

http://aidsinfo.nih.gov/news/1376/antiretroviral-drugs-may-protect-against-puberty-delays-in-hiv-infected-children

FDA Approves New Drug to Treat HIV Infection

Date: August 12, 2013

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/1375/fda-approves-new-drug-to-treat-hiv-infection

Antiretroviral Drugs Taken by HIV-Infected Women in Pregnancy Not Linked to Children's Language Delays

Date: July 18, 2013

Source: National Institutes of Health (NIH) - no specific institute

http://aidsinfo.nih.gov/news/1372/antiretroviral-drugs-taken-by-hiv-infected-women-in-pregnancy-not-linked-to-childrens-language-delays

Study Finds First Evidence That PrEP Can Reduce HIV Risk Among People Who Inject Drugs

Date: June 12, 2013

Source: Centers for Disease Control and Prevention (CDC)

Author: National Center for HIV, STD, and TB Prevention (NCHHSTP)

http://aidsinfo.nih.gov/news/1362/study-finds-first-evidence-that-prep-can-reduce-hiv-risk-among-people-who-inject-drugs

FDA Publishes New Guidance for Industry on Developing Antiretroviral Drugs for HIV Treatment

Date: June 5, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm355956.htm

FDA to Hold Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research

Date: May 13, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm352122.htm

FDA Updates Efavirenz Labeling with New Indication and Pediatric Patient Information

Date: May 3, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm350744.htm

FDA Updates Darunavir Labeling with New Clinical Trial Data

Date: April 25, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm349445.htm

NIH Network Study Shows That HAART Appears to Protect Children's Hearts

Date: April 22, 2013

Source: National Institutes of Health (NIH)

Author: National Institute of Child Health and Human Development (NICHD)

http://aidsinfo.nih.gov/news/1346/nih-network-study-shows-that-haart-appears-to-protect-childrens-hearts

FDA Updates Atripla Tablet Label with New Information in the Warnings and Precautions, Drug Interactions, and Nursing Mothers Sections

Date: April 17, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm348508.htm

Daily-Use HIV Prevention Approaches Prove Ineffective Among Women in NIH Study

Date: March 4, 2013

Source: National Institutes of Health (NIH) - no specific institute

http://aidsinfo.nih.gov/news/1336/daily-use-hiv-prevention-approaches-prove-ineffective-among-women-in-nih-study-

NIH-Supported Researchers Report Toddler "Functionally Cured" of HIV Infection

Date: March 3, 2013

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/1333/nih-supported-researchers-report-toddler-"functionally-cured"-of-hiv-infection

FDA Updates Darunavir Label with New Drug Interaction Information

Date: March 1, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm342033.htm

FDA Updates Etravirine Label with New Warnings and Precautions, Adverse Reactions, and Drug Interactions Information

Date: March 1, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm342032.htm

FDA Updates Atazanavir Sulfate Capsule Labeling with Adverse Reaction and Drug Interaction Information

Date: February 4, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm339009.htm

FDA Updates Darunavir Tablet and Oral Suspension Labeling with Pediatric Dosing Information

Date: February 1, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm337778.htm

FDA Updates Complera Label with New Indication and Clinical Trial Information

Date: January 25, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm337007.htm

FDA Updates Lopinavir/Ritonavir Labeling to Include New Drug Interaction Information

Date: January 22, 2013

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm336367.htm

FDA Approves First Anti-Diarrheal Drug for Individuals with HIV/AIDS

Date: December 31, 2012

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/1317/fda-approves-first-anti-diarrheal-drug-for-individuals-with-hiv-aids-

FDA Updates Rilpivirine Label with New Indication and Clinical Trial Data

Date: December 10, 2012

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm331574.htm

FDA Updates Adefovir Dipivoxil Label with Safety Information on Stribild

Date: November 30, 2012

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm330240.htm

HIV Treatment Reduces Risk of Malaria Recurrence in Children

Date: November 28, 2012

Source: National Institutes of Health (NIH) - no specific institute

http://aidsinfo.nih.gov/news/1306/hiv-treatment-reduces-risk-of-malaria-recurrence-in-children

FDA Releases Draft Guidance on Vaginal Microbicides for the Prevention of HIV

Date: November 26, 2012

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm329466.htm

FDA Approves 800-mg Tablet Strength for Darunavir

Date: November 14, 2012

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm328097.htm

FDA Updates Label for Nevirapine to Include New 100-mg Tablet, Dosing Information in Children

Date: November 14, 2012

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm328098.htm

AIDSinfo Launches Redesigned Drug Database

Date: September 28, 2012

Source: AIDSinfo

http://aidsinfo.nih.gov/drugs/

NIH-Funded Analysis Estimates Effective PrEP Dosing

Date: September 13, 2012

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/1279/nih-funded-analysis-estimates-effective-prep-dosing

FDA Approves New Combination Pill for HIV Treatment for Some Individuals

Date: August 27, 2012

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/1275/fda-approves-new-combination-pill-for-hiv-treatment-for-some-individuals

CDC Issues Interim Guidance on Use of Medication to Prevent HIV Infection

Date: August 9, 2012

Source: Centers for Disease Control and Prevention (CDC)

Author: National Center for HIV, STD, and TB Prevention (NCHHSTP)

http://aidsinfo.nih.gov/news/1269/cdc-issues-interim-guidance-on-use-of-medication-to-prevent-hiv-infection

HPTN 052 Study Demonstrates Additional Health Benefits, Cost-Effectiveness

Date: July 27, 2012

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/1266/hptn-052-study-demonstrates-additional-health-benefits-cost-effectiveness

NIH to Test Dapivirine Vaginal Ring for HIV Prevention in Women

Date: July 24, 2012

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/1260/nih-to-test-dapivirine-vaginal-ring-for-hiv-prevention-in-women

NIH Scientists to Test Maraviroc-Based Drug Regimens for HIV Prevention

Date: July 18, 2012

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/1257/nih-scientists-to-test-maraviroc-based-drug-regimens-for-hiv-prevention

CDC Statement on FDA Approval of Truvada for HIV Prevention

Date: July 16, 2012

Source: Centers for Disease Control and Prevention (CDC)

Author: National Center for HIV, STD, and TB Prevention (NCHHSTP)

http://aidsinfo.nih.gov/news/1256/cdc-statement-on-fda-approval-of-truvada-for-hiv-prevention

FDA Approves First Drug (Truvada) for Reducing the Risk of HIV Infection

Date: July 16, 2012

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/1254/fda-approves-first-drug-(truvada)-for-reducing-the-risk-of-hiv-infection

Adding Nevirapine to HIV Regimen Halves Newborn Transmission Rate

Date: June 20, 2012

Source: National Institutes of Health (NIH)

Author: National Institute of Child Health and Human Development (NICHD)

http://aidsinfo.nih.gov/news/1251/adding-nevirapine-to-hiv-regimen-halves-newborn-transmission-rate

FDA Approves Generic Formulation of Abacavir Tablets

Date: June 19, 2012

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm309085.htm

FDA Launches New Website with Information on the Development of Microbicides

Date: June 7, 2012

Source: Food and Drug Administration (FDA)

http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/Overview/ucm077763.htm

FDA Updates Darunavir Label with Safety Information

Date: June 1, 2012

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm306449.htm

FDA Approves Generic Formulations of Nevirapine

Date: May 24, 2012

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm305654.htm

FDA Approves Generic Formulation of Lamivudine and Zidovudine Tablets

Date: May 23, 2012

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm305490.htm

Anti-HIV Drug Use During Pregnancy Does Not Affect Infant Size, Birth Weight

Date: May 1, 2012

Source: National Institutes of Health (NIH)

http://aidsinfo.nih.gov/news/1232/anti-hiv-drug-use-during-pregnancy-does-not-affect-infant-size-birth-weight

FDA Approves New Pediatric Dosing Recommendations for Fosamprenavir

Date: April 30, 2012

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/1231/fda-approves-new-pediatric-dosing-recommendations-for-fosamprenavir

FDA Issues Safety Announcement on Interactions Between Boceprevir and Certain PIs

Date: April 26, 2012

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/1230/fda-issues-safety-announcement-on-interactions-between-boceprevir-and-certain-pis

FDA Approves New Pediatric Dosing Recommendations for Etravirine

Date: March 26, 2012

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/1223/fda-approves-new-pediatric-dosing-recommendations-for-etravirine

FDA Expands Use of Isentress to Children & Adolescents

Date: December 21, 2011

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/919/fda-expands-use-of-isentress-to-children--adolescents

Short Course INH-RPT in Patients Taking ARVs

Date: December 20, 2011

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/contentfiles/Short_Course_INH-RPT.pdf

Cholesterol Levels Elevated In Toddlers Taking Anti-HIV Drugs

Date: November 21, 2011

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/915/cholesterol-levels-elevated-in-toddlers-taking-anti-hiv-drugs

Isentress (raltegravir) package insert updated

Date: November 2, 2011

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm278378.htm

Supplemental Information Regarding the Role of Rilpivirine (RPV) as Initial Therapy - August 16, 2011

Date: August 16, 2011

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/contentfiles/NNRTI_One_Page_Info-RPV.pdf

Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination - August 10, 2011

Date: August 10, 2011

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/909/approval-of-complera-emtricitabine-rilpivirine-tenofovir-df-fixed-dose-combination---august-10-2011

Fluconazole and birth defects - chronic use in pregnancy (outside of vaginal candidiasis) now FDA pregnancy class D - August 4, 2011

Date: August 4, 2011

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/contentfiles/Fluconazole_FDA_Drug_Safety.pdf

CDC Trial and Another Major Study Find PrEP Can Reduce Risk of HIV Infection among Heterosexuals - July 13, 2011

Date: July 13, 2011

Source: Centers for Disease Control and Prevention (CDC)

Author: National Center for HIV, STD, and TB Prevention (NCHHSTP)

http://aidsinfo.nih.gov/news/907/cdc-trial-and-another-major-study-find-prep-can-reduce-risk-of-hiv-infection-among-heterosexuals---july-13-2011

Approval of generic formulation of lamivudine and zidovudine tablets, 150 mg/300 mg - May 25, 2011

Date: May 25, 2011

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/903/approval-of-generic-formulation-of-lamivudine-and-zidovudine-tablets-150-mg-300-mg---may-25-2011

Approval of Edurant (rilpivirine), a new NNRTI, for the Treatment of HIV in Treatment Naive Patients - May 20, 2011

Date: May 20, 2011

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm256151.htm

Treating HIV-infected People with Antiretrovirals Protects Partners from Infection - May 12, 2011

Date: May 12, 2011

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/901/treating-hiv-infected-people-with-antiretrovirals-protects-partners-from-infection---may-12-2011

Update to Fuzeon (enfuvirtide) label regarding incidence of bacterial pneumonia - April 28, 2011

Date: April 28, 2011

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm253417.htm

The FEM-PrEP HIV Prevention Study and Its Implications for NIAID Research - April 18, 2011

Date: April 18, 2011

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/899/the-fem-prep-hiv-prevention-study-and-its-implications-for-niaid-research---april-18-2011

NIH Study Examines Best Time for Healthy HIV-infected People to Begin Antiretrovirals - March 7, 2011

Date: March 7, 2011

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/896/nih-study-examines-best-time-for-healthy-hiv-infected-people-to-begin-antiretrovirals---march-7-2011

Safety Review update of Abacavir: no statistically significant association seen between myocardial infarction and ABC - March 1, 2011

Date: March 1, 2011

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm245247.htm

Kaletra (lopinavir/ritonavir) Oral Solution label changes related to toxicity in preterm neonates - February 24, 2011

Date: February 24, 2011

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm244639.htm

Viracept (nelfinavir) Label change reflects drug-drug interaction information with warfarin - February 24, 2011

Date: February 24, 2011

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm244619.htm

New Intelence (etravirine) dosage approved - December 22, 2010

Date: December 22, 2010

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm238057.htm

FDA approves Egrifta to treat Lipodystrophy in HIV patients - November 10, 2010

Date: November 10, 2010

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/889/fda-approves-egrifta-to-treat-lipodystrophy-in-hiv-patients---november-10-2010

FDA Approves Egrifta to Treat Lipodystrophy in HIV Patients - November 10, 2010

Date: November 10, 2010

Source: Food and Drug Administration (FDA)

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm233516.htm

NIH Network Identifies Better Treatment Regimen for HIV-Infected Infants - November 3, 2010

Date: November 3, 2010

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/888/nih-network-identifies-better-treatment-regimen-for-hiv-infected-infants---november-3-2010

FDA Drug Safety Communication: Invirase (saquinavir) labels now contain updated risk information on abnormal heart rhythms - October 21, 2010

Date: October 21, 2010

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/887/fda-drug-safety-communication-invirase-(saquinavir)-labels-now-contain-updated-risk-information-on-abnormal-heart-rhythms---october-21-2010

Invirase (saquinavir) labels now contain updated risk information on abnormal heart rhythms - October 21, 2010

Date: October 21, 2010

Source: Food and Drug Administration (FDA)

http://www.fda.gov/Drugs/DrugSafety/ucm230096.htm#safety/

FDA Drug Safety Communication: New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients

Date: September 15, 2010

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/881/fda-drug-safety-communication-new-dosing-recommendations-to-prevent-potential-valcyte-(valganciclovir)-overdose-in-pediatric-transplant-patients

New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients - September 15, 2010

Date: September 15, 2010

Source: Food and Drug Administration (FDA)

http://www.fda.gov/Drugs/DrugSafety/ucm225727.htm

NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB - July 22, 2010

Date: July 22, 2010

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/880/nih-funded-study-finds-early-haart-during-tb-treatment-boosts-survival-rate-in-people-co-infected-with-hiv-and-tb---july-22-2010

NIH Scientist Anthony S. Fauci to Address Early HIV Infection and a Novel Target for HIV Vaccine Development - July 20, 2010

Date: July 20, 2010

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/879/nih-scientist-anthony-s-fauci-to-address-early-hiv-infection-and-a-novel-target-for-hiv-vaccine-development---july-20-2010

Increased Use of Treatment Leads to Reduction in New Diagnoses

Date: July 18, 2010

Source: National Institutes of Health (NIH)

Author: National Institute on Drug Abuse (NIDA)

http://aidsinfo.nih.gov/news/877/increased-use-of-treatment-leads-to-reduction-in-new-diagnoses-

Isentress (raltegravir potassium) label update reflects 96 week safety/efficacy results in treatment-naive and treatment-experienced patients - June 30, 2010

Date: June 30, 2010

Source: National Institutes of Health (NIH)

Author: National Institute on Drug Abuse (NIDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm217750.htm

Isentress (raltegravir potassium) label update reflects 96 week safety/efficacy results in treatment-naive and treatment-experienced patients

Date: June 29, 2010

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/872/isentress-(raltegravir-potassium)-label-update-reflects-96-week-safety-efficacy-results-in-treatment-naive-and-treatment-experienced-patients

Selzentry (maraviroc) labeling changes for patients with renal impairment

Date: May 27, 2010

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/873/selzentry-(maraviroc)-labeling-changes-for-patients-with-renal-impairment

New Kaletra (lopinavir/ritonavir) Tablets and Oral Solution once daily dosing regimen in certain adult patients

Date: April 28, 2010

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/864/new-kaletra-(lopinavir-ritonavir)-tablets-and-oral-solution-once-daily-dosing-regimen-in-certain-adult-patients

New Kaletra (lopinavir/ritonavir) Tablets and Oral Solution once daily dosing regimen in certain adult patients - April 28, 2010

Date: April 28, 2010

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm209940.htm

New label information affecting all approved protease inhibitors for treatment of HIV

Date: April 27, 2010

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/863/new-label-information-affecting-all-approved-protease-inhibitors-for-treatment-of-hiv

Updated label information for Sustiva (efavirenz)

Date: April 14, 2010

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/865/updated-label-information-for-sustiva-(efavirenz)

Intelence (etravirine) label revised to include new drug-drug interaction information - March 11, 2010

Date: March 11, 2010

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm204217.htm

Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms - February 23, 2010

Date: February 23, 2010

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/1068/ongoing-safety-review-of-invirase-(saquinavir)-and-possible-association-with-abnormal-heart-rhythms---february-23-2010

Kaletra (lopinavir/ritonavir) package insert revision regarding drug-drug interaction information - February 1, 2010

Date: February 1, 2010

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm199270.htm

FDA Drug Safety Communication: Serious liver disorder associated with the use of Videx/Videx EC (didanosine)

Date: January 29, 2010

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/857/fda-drug-safety-communication-serious-liver-disorder-associated-with-the-use-of-videx-videx-ec-(didanosine)

Serious Liver Disorder Associated with the use of Videx/Videx EC (didanosine) - January 29, 2010

Date: January 29, 2010

Source: Food and Drug Administration (FDA)

http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm199169.htm

Prezista (darunavir) labeling changes reflect 96 week study data - January 27, 2010

Date: January 28, 2010

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm199204.htm

Atripla label update reflects new efficacy, safety and resistance data in treatment experienced patients - January 7, 2010

Date: January 8, 2010

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm196950.htm

Important information about Lexiva (fosamprenavir calcium) Tablets and Oral Suspension - December 4, 2009

Date: December 4, 2009

Source: Food and Drug Administration (FDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm192905.htm

Tenofovir/ Emtricitabine Performs Better than Abacavir/ Lamivudine in Subgroup of Antiretroviral-Naïve, HIV-Infected Individuals - December 2, 2009

Date: December 2, 2009

Source: Food and Drug Administration (FDA)

http://www3.niaid.nih.gov/news/newsreleases/2009/TenofovirEmtricitabine.htm

Tenofovir/Emtricitabine Performs Better than Abacavir/Lamivudine in Subgroup of Antiretroviral-Naïve, HIV-Infected Individuals

Date: December 1, 2009

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/851/tenofovir-emtricitabine-performs-better-than-abacavir-lamivudine-in-subgroup-of-antiretroviral-naïve-hiv-infected-individuals

Intelence (etravirine) label updated to reflect dosing data through 48 weeks - 25 November, 2009

Date: November 25, 2009

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm192039.htm

Expanded indication for Selzentry (maraviroc) - November 24, 2009

Date: November 24, 2009

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm191962.htm

Important label update for Norvir (ritonavir) - November 24, 2009

Date: November 24, 2009

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm191853.htm

New dosing recommendations Retrovir (zidovudine) syrup for HIV-infected infants - November 10, 2009

Date: November 11, 2009

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/1167/new-dosing-recommendations-retrovir-(zidovudine)-syrup-for-hiv-infected-infants---november-10-2009

FDA Issues a Safety Warning for Etravirine - August 26, 2009

Date: August 26, 2009

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm180480.htm

Starting Antiretroviral Therapy Earlier Yields Better Clinical Outcomes : Interim Review Leads to Early End of Clinical Trial in Haiti

Date: June 8, 2009

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/836/starting-antiretroviral-therapy-earlier-yields-better-clinical-outcomes--interim-review-leads-to-early-end-of-clinical-trial-in-haiti

IL-2 Immunotherapy Fails to Benefit HIV-Infected Individuals Already Taking Antiretrovirals

Date: February 10, 2009

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/824/il-2-immunotherapy-fails-to-benefit-hiv-infected-individuals-already-taking-antiretrovirals

Anti-HIV Gel Shows Promise in Large-scale Study in Women

Date: February 9, 2009

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/826/anti-hiv-gel-shows-promise-in-large-scale-study-in-women

Anti-HIV `Drug Cocktails¿ Equally Effective in Patients with or without History of Injection Drug Use

Date: August 6, 2008

Source: National Institutes of Health (NIH)

Author: National Institute on Drug Abuse (NIDA)

http://aidsinfo.nih.gov/news/819/anti-hiv-`drug-cocktails¿-equally-effective-in-patients-with-or-without-history-of-injection-drug-use

NIDA: HAART Equally Effective in Patients with or without History of Injection Drug Use - August 6, 2008

Date: August 6, 2008

Source: National Institutes of Health (NIH)

Author: National Institute on Drug Abuse (NIDA)

http://www.nih.gov/news/health/aug2008/nida-06.htm

Dear Healthcare Professional Letter Issued: Important Information for Prescribers about Viracept (Nelfinavir) - May 9, 2008

Date: May 9, 2008

Source: National Institutes of Health (NIH)

Author: National Institute on Drug Abuse (NIDA)

http://aidsinfo.nih.gov/contentfiles/NFV_prescribing_info.pdf

Adult Guidelines Panel Issues a Communication on Abacavir - April 4, 2008

Date: April 4, 2008

Source: National Institutes of Health (NIH)

Author: National Institute on Drug Abuse (NIDA)

http://aidsinfo.nih.gov/contentfiles/ABCComm.pdf

FDA Approves New NNRTI, Etravirine - January 18, 2008

Date: January 24, 2008

Source: National Institutes of Health (NIH)

Author: National Institute on Drug Abuse (NIDA)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm124019.htm

FDA Approves New HIV Drug After Priority Review

Date: January 18, 2008

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/807/fda-approves-new-hiv-drug-after-priority-review

FDA Approves the First Integrase Inhibitor, Raltegravir - October 12, 2007

Date: October 12, 2007

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/803/fda-approves-the-first-integrase-inhibitor-raltegravir---october-12-2007

FDA Antiviral Drugs Advisory Committee Recommends Accelerated Approval of Raltegravir - September 5, 2007

Date: September 26, 2007

Source: Food and Drug Administration (FDA)

http://www.cdcnpin.org/scripts/display/NewsDisplay.asp?NewsNbr=49021

DHHS Perinatal Panel Notice on Nelfinavir FDA-Pfizer Letter - September 11, 2007

Date: September 11, 2007

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/contentfiles/PeriNFVNotice1.pdf

HIV Protease Inhibitors Show Potential as Cancer Treatments

Date: September 1, 2007

Source: National Institutes of Health (NIH)

Author: National Cancer Institute (NCI)

http://aidsinfo.nih.gov/news/801/hiv-protease-inhibitors-show-potential-as-cancer-treatments

FDA Approves HIV-Entry Inhibitor Maraviroc - August 6, 2007

Date: August 7, 2007

Source: National Institutes of Health (NIH)

Author: National Cancer Institute (NCI)

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm124198.htm

Approval of maraviroc

Date: August 6, 2007

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/800/approval-of-maraviroc

Treating HIV-Infected Infants Early Helps Them Live Longer

Date: July 25, 2007

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/798/treating-hiv-infected-infants-early-helps-them-live-longer

FDA approval of Lexiva oral suspension and label changes for pediatric patients and patients with hepatic impairment

Date: June 18, 2007

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/796/fda-approval-of-lexiva-oral-suspension-and-label-changes-for-pediatric-patients-and-patients-with-hepatic-impairment

NIDA Looks at Non-Injection Drug Use and Spread of HIV/AIDS

Date: May 8, 2007

Source: National Institutes of Health (NIH)

Author: National Institute on Drug Abuse (NIDA)

http://aidsinfo.nih.gov/news/794/nida-looks-at-non-injection-drug-use-and-spread-of-hiv-aids

FDA Advisory Committee Recommends Accelerated Approval of HIV Entry Inhibitor, Maraviroc - April 24, 2007

Date: April 27, 2007

Source: National Institutes of Health (NIH)

Author: National Institute on Drug Abuse (NIDA)

http://www.aidsinfo.nih.gov/ListServ/PreviewPage.aspx?pageID=28

FDA Grants Tentative Approval to Generic Formulation of Stavudine - April 24, 2007

Date: April 24, 2007

Source: National Institutes of Health (NIH)

Author: National Institute on Drug Abuse (NIDA)

http://www.fda.gov/oashi/aids/listserve/listserve2007.html#042307/

Product Labeling for Kaletra (lopinavir/ritonavir) Updated with New Safety and Efficacy Data - April 24th, 2007

Date: April 24, 2007

Source: National Institutes of Health (NIH)

Author: National Institute on Drug Abuse (NIDA)

http://www.fda.gov/oashi/aids/listserve/listserve2007.html#42307/

Important Notice about Combivir and Ziagen

Date: April 10, 2007

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/791/important-notice-about-combivir-and-ziagen

FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)-March 9, 2007

Date: March 9, 2007

Source: Food and Drug Administration (FDA)

http://www.fda.gov/bbs/topics/NEWS/2007/NEW01582.html

NIH Release--New Paradigm Will Help Identify Leads for Drug Discovery--July 24, 2006

Date: February 6, 2007

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/938/nih-release--new-paradigm-will-help-identify-leads-for-drug-discovery--july-24-2006

NIH Release--Women's Response to Anti-HIV Therapy Improved If Treatment Begins Six Months After Earlier Preventive RegimenResponse to Treatment Diminished If Treatment Begins Within Six Months Of Preventive Regimen, January 10, 2007

Date: January 10, 2007

Source: Food and Drug Administration (FDA)

news/938/nih-release--new-paradigm-will-help-identify-leads-for-drug-discovery--july-24-2006/

WOMEN'S RESPONSE TO ANTI-HIV THERAPY IMPROVED IF TREATMENT BEGINS SIX MONTHS AFTER EARLIER PREVENTIVE REGIMEN

Date: January 10, 2007

Source: National Institutes of Health (NIH)

Author: Office of the Director (OD) of NIH

http://aidsinfo.nih.gov/news/781/womens-response-to-anti-hiv-therapy-improved-if-treatment-begins-six-months-after-earlier-preventive-regimen

International HIV/AIDS Trial Finds that Risks of Death, AIDS and Other Major Diseases Increase on Episodic Antiretroviral Therapy

Date: November 29, 2006

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/780/international-hiv-aids-trial-finds-that-risks-of-death-aids-and-other-major-diseases-increase-on-episodic-antiretroviral-therapy

Atazanavir Labeling Changes

Date: November 27, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/750/atazanavir-labeling-changes

Food and Drug Administration Approved New 300 mg Capsule Form of Reyataz--October 16, 2006

Date: October 16, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/contentfiles/FDA-10_25_06-New300mgReyatazApproved.pdf

Tentative approval of lamivudine/zidovudine copackaged with abacavir sulfate

Date: July 26, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/771/tentative-approval-of-lamivudine-zidovudine-copackaged-with-abacavir-sulfate

FDA Approves the First Once-a-Day Three-Drug Combination Tablet for Treatment of HIV-1

Date: July 12, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/769/fda-approves-the-first-once-a-day-three-drug-combination-tablet-for-treatment-of-hiv-1

FDA Grants Tentative Approval of a Three-Component AIDS Drug

Date: June 30, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/768/fda-grants-tentative-approval-of-a-three-component-aids-drug

Important safety information about Aptivus ( tipranavir)

Date: June 30, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/767/important-safety-information-about-aptivus-(-tipranavir)

FDA Approves New HIV Treatment for Patients Who Do Not Respond to Existing Drugs

Date: June 27, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/764/fda-approves-new-hiv-treatment-for-patients-who-do-not-respond-to-existing-drugs

FDA Gives Tentative Approval for Another First Time Generic Pediatric AIDS Drug in Association with the President's Emergency Plan for AIDS Relief

Date: June 27, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/765/fda-gives-tentative-approval-for-another-first-time-generic-pediatric-aids-drug-in-association-with-the-presidents-emergency-plan-for-aids-relief

FDA Approval of Prezista

Date: June 26, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/763/fda-approval-of-prezista

FDA Approval of Prezista--June 26, 2006

Date: June 26, 2006

Source: Food and Drug Administration (FDA)

http://www.fda.gov/bbs/topics/NEWS/2006/NEW01395.html

FDA--GARDASIL: Questions and Answers--June 8, 2006

Date: June 12, 2006

Source: Food and Drug Administration (FDA)

http://www.fda.gov/cber/products/hpvmer060806qa.htm

FDA Release--New Guidance on Antiviral Product Development--June 9, 2006

Date: June 9, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/ContentFiles/FDA-6_8_06.pdf

AIDS Drugs Have Saved 3 Million Years of Life in the United States--NIH Press Release, June 2, 2006

Date: June 7, 2006

Source: Food and Drug Administration (FDA)

http://www.niaid.nih.gov/news/newsreleases/2006/AIDSsurvival.htm

Generic zidovudine in Capsule Form

Date: March 31, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/757/generic-zidovudine-in-capsule-form

FDA Grants Traditional Approval of Viread and Truvada--March 8, 2006

Date: March 14, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/ContentFiles/FDA-3_14_06.pdf

Traditional Approval of Viread and Truvada

Date: March 8, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/755/traditional-approval-of-viread-and-truvada

FDA Label Changes for Atazanavir--January 30, 2006

Date: January 30, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/ContentFiles/SummaryLabelChangesAtazanavir.pdf

FDA Announces New Prescription Drug Information Format to Improve Patient Safety--January 19, 2006

Date: January 20, 2006

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/ContentFiles/FDA-NewPresDrugImprovePatientSafety.pdf

International HIV/AIDS Trial Finds Continuous Antiretroviral Therapy Superior to Episodic Therapy

Date: January 18, 2006

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/748/international-hiv-aids-trial-finds-continuous-antiretroviral-therapy-superior-to-episodic-therapy

Strategies for Management of Anti-Retroviral Therapy (SMART) Trial Q & A's--January 18, 2006

Date: January 18, 2006

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/ContentFiles/SMART_trial_ends_early_QA.pdf

FDA approves New Formulation of Kaletra--October 28, 2005

Date: November 1, 2005

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/other/2FDA-10_31_05.pdf

FDA approval of new formulation of Kaletra

Date: October 28, 2005

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/745/fda-approval-of-new-formulation-of-kaletra

Emtriva: New Formulation and Labeling Changes

Date: September 29, 2005

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/741/emtriva-new-formulation-and-labeling-changes

FDA Approves First Pediatric Generic AIDS Drug for U.S. Marketing

Date: September 19, 2005

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/740/fda-approves-first-pediatric-generic-aids-drug-for-us-marketing

Tentative Approval Generic Zidovudine Oral Solution

Date: September 7, 2005

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/737/tentative-approval-generic-zidovudine-oral-solution

FDA Approval of Aptivus (tipranavir)

Date: June 21, 2005

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/731/fda-approval-of-aptivus-(tipranavir)

FDA Tentatively Approves First Generic Nevirapine under the President's Emergency Plan for AIDS Relief

Date: June 20, 2005

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/732/fda-tentatively-approves-first-generic-nevirapine-under-the-presidents-emergency-plan-for-aids-relief

FDA Tentatively Approves a Generic AIDS Drug under the President's Emergency Plan for AIDS Relief

Date: June 15, 2005

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/733/fda-tentatively-approves-a-generic-aids-drug-under-the-presidents-emergency-plan-for-aids-relief

FDA Approves Generic Version of Foscavir

Date: May 31, 2005

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/730/fda-approves-generic-version-of-foscavir

Dear Health Care Provider Letter Regarding the Discontinuation of Fortovase

Date: May 26, 2005

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/729/dear-health-care-provider-letter-regarding-the-discontinuation-of-fortovase

FDA Approved the use of KALETRA, Once-daily Administration for the Treatment of HIV-infection in Therapy-naïve Adults--April 29,2005

Date: April 29, 2005

Source: Food and Drug Administration (FDA)

http://www.aidsinfo.nih.gov/other/FDAKaletra.pdf

FDA Approves Once-Daily Dosage of Kaletra for Therapy-Naïve Adult Patients

Date: April 29, 2005

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/728/fda-approves-once-daily-dosage-of-kaletra-for-therapy-naïve-adult-patients

Important Change in SUSTIVA (efavirenz) Package Insert — Change from Pregnancy Category C to D--March 31, 2005

Date: April 1, 2005

Source: Food and Drug Administration (FDA)

#/##

FDA Public Health Advisory for Nevirapine (Viramune)-January 19, 2005

Date: January 19, 2005

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/723/fda-public-health-advisory-for-nevirapine-(viramune)-january-19-2005

New 500 mg Tablet Formulation of Invirase (saquinavir) Approved

Date: December 21, 2004

Source: Food and Drug Administration (FDA)

http://www.fda.gov/oashi/aids/listserve/listserve2004.html#invir500/

New information about coadministration of REYATAZ (atazanavir) and Norvir (ritonavir) with Prilosec (omeprazole) - December 20, 2004

Date: December 20, 2004

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/722/new-information-about-coadministration-of-reyataz-(atazanavir)-and-norvir-(ritonavir)-with-prilosec-(omeprazole)---december-20-2004

FDA approves generic formulation of didanosine (ddI) delayed release capsules

Date: December 3, 2004

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/721/fda-approves-generic-formulation-of-didanosine-(ddi)-delayed-release-capsules

Treating Opportunistic Infections Among HIV-Exposed and Infected Children - November 23, 2004

Date: December 3, 2004

Source: Food and Drug Administration (FDA)

http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5314a1.htm

Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents - December 17, 2004

Date: December 3, 2004

Source: Food and Drug Administration (FDA)

http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5315a1.htm

FDA Approves Sculptra for HIV Patients

Date: August 3, 2004

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/709/fda-approves-sculptra-for-hiv-patients

FDA Approves Two Fixed-Dose Combination Drug Products For the Treatment of HIV-1 Infection

Date: August 2, 2004

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/710/fda-approves-two-fixed-dose-combination-drug-products-for-the-treatment-of-hiv-1-infection

Researchers Identify Better Hepatitis C Treatment for People with HIV

Date: July 19, 2004

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/708/researchers-identify-better-hepatitis-c-treatment-for-people-with-hiv

Weekly Cycles of Once-Daily Anti-Drugs Could Reduce Cost of HIV Treatment

Date: May 24, 2004

Source: National Institutes of Health (NIH)

http://aidsinfo.nih.gov/news/704/weekly-cycles-of-once-daily-anti-drugs-could-reduce-cost-of-hiv-treatment

HHS Proposes Rapid Process For Review of Fixed Dose Combination and Co-Packaged Products

Date: May 16, 2004

Source: Department of Health and Human Services (DHHS)

http://aidsinfo.nih.gov/news/705/hhs-proposes-rapid-process-for-review-of-fixed-dose-combination-and-co-packaged-products

Label Changes for Crixivan - May 2004

Date: May 13, 2004

Source: Department of Health and Human Services (DHHS)

http://www.fda.gov/cder/foi/label/2004/20685slr046,047_crixivan_lbl.pdf

Guidance for Industry: Fixed Dose Combination and Co-Packaged Drug Products for Treatment of HIV

Date: May 1, 2004

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/703/guidance-for-industry-fixed-dose-combination-and-co-packaged-drug-products-for-treatment-of-hiv

HIV Patients Get Long-Term Boost with Short, Intermittent Drug Regimen

Date: April 26, 2004

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/702/hiv-patients-get-long-term-boost-with-short-intermittent-drug-regimen

Joint Statement Issued Regarding Principles For Fixed-Dose Combination Drug Products

Date: April 8, 2004

Source: Department of Health and Human Services (DHHS)

http://aidsinfo.nih.gov/news/701/joint-statement-issued-regarding-principles-for-fixed-dose-combination-drug-products

FDA Issues Draft Guidance on Providing More Information on Investigational Treatment

Date: January 27, 2004

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/692/fda-issues-draft-guidance-on-providing-more-information-on-investigational-treatment

Drug errors involving Keppra and Kaletra

Date: January 12, 2004

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/690/drug-errors-involving-keppra-and-kaletra

Combination, Order of Anti-HIV Drugs Make a Difference in First-time Recipients

Date: December 10, 2003

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/685/combination-order-of-anti-hiv-drugs-make-a-difference-in-first-time-recipients

Revisions to Kaletra (lopinavir/ritonavir) labeling

Date: December 9, 2003

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://www.fda.gov/cder/foi/label/2003/21226slr012,21251slr009_kaletra_lbl.pdf

FDA Approves LEXIVA (Fosamprenavir calcium) to Treat HIV Infection

Date: October 21, 2003

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/682/fda-approves-lexiva-(fosamprenavir-calcium)-to-treat-hiv-infection

Drug Warning: Once-daily Triple NRTI Regimen containing Didanosine, Lamivudine, and Tenofovir

Date: October 14, 2003

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/681/drug-warning-once-daily-triple-nrti-regimen-containing-didanosine-lamivudine-and-tenofovir

New Live Attenuated Influenza Vaccine (FluMist) Not Recommended for People with HIV or their Close Contacts

Date: October 9, 2003

Source: Food and Drug Administration (FDA)

http://aidsetc.org/aidsetc?page=et-02-00-03

Nevirapine Sustains Advantage Over AZT During Breastfeeding Period

Date: September 11, 2003

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/676/nevirapine-sustains-advantage-over-azt-during-breastfeeding-period

Treatment Interruption Shows No Benefit in Drug-Resistant HIV Infection

Date: August 27, 2003

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/675/treatment-interruption-shows-no-benefit-in-drug-resistant-hiv-infection

Important New Pharmacokinetic Data for REYATAZ(tm) (atazanavir sulfate) in combination with Viread® (tenofovir disoproxil fumarate)

Date: August 8, 2003

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/674/important-new-pharmacokinetic-data-for-reyataz(tm)-(atazanavir-sulfate)-in-combination-with-viread®-(tenofovir-disoproxil-fumarate)

CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection

Date: July 31, 2003

Source: Centers for Disease Control and Prevention (CDC)

http://aidsinfo.nih.gov/news/673/cdc-recommendations-against-the-use-of-rifampin-and-pyrazinamide-for-treatment-of-latent-tuberculosis-infection

Revised Guidelines Will Ease Selection of HIV/AIDS Treatments

Date: July 14, 2003

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/677/revised-guidelines-will-ease-selection-of-hiv-aids-treatments

FDA Approves a Once Daily Protease Inhibitor for HIV Infection

Date: June 20, 2003

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/669/fda-approves-a-once-daily-protease-inhibitor-for-hiv-infection

Discovery Lays Groundwork for Potential New Class of Anti-HIV Drugs

Date: March 31, 2003

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/661/discovery-lays-groundwork-for-potential-new-class-of-anti-hiv-drugs

FDA Approves First Drug in New Class of HIV Treatments

Date: March 13, 2003

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/655/fda-approves-first-drug-in-new-class-of-hiv-treatments

Important Interim Results from a Phase III, Randomized, Double-Blind Comparison of Three Protease-Inhibitor-Sparing Regimens for the Initial Treatment of HIV Infection (AACTG Protocol A5095)

Date: March 13, 2003

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/656/important-interim-results-from-a-phase-iii-randomized-double-blind-comparison-of-three-protease-inhibitor-sparing-regimens-for-the-initial-treatment-of-hiv-infection-(aactg-protocol-a5095)

FDA Proposes New Warning for Over-The-Counter Contraceptive Drugs Containing Nonoxynol-9

Date: January 16, 2003

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/648/fda-proposes-new-warning-for-over-the-counter-contraceptive-drugs-containing-nonoxynol-9

Preventive Therapy for Non-Occupational Exposures

Date: January 1, 2003

Source: Centers for Disease Control and Prevention (CDC)

http://aidsinfo.nih.gov/news/659/preventive-therapy-for-non-occupational-exposures

Food and Drug Administration approved a new, extended release formulation of ZERIT

Date: December 31, 2002

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/646/food-and-drug-administration-approved-a-new-extended-release-formulation-of-zerit

Bush Administration will Seek New Legislation for Mandatory Pediatric Drug Testing

Date: December 16, 2002

Source: Department of Health and Human Services (DHHS)

http://aidsinfo.nih.gov/news/645/bush-administration-will-seek-new-legislation-for-mandatory-pediatric-drug-testing

Study Sheds Light on Cause of an AIDS Treatment Side Effect

Date: September 12, 2002

Source: National Institutes of Health (NIH)

Author: National Cancer Institute (NCI)

http://aidsinfo.nih.gov/news/629/study-sheds-light-on-cause-of-an-aids-treatment-side-effect

Majority of HIV-Infected Mothers and At-Risk Newborns Receive ZDV Treatment in Groundbreaking Thailand Prevention Program

Date: July 6, 2002

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/624/majority-of-hiv-infected-mothers-and-at-risk-newborns-receive-zdv-treatment-in-groundbreaking-thailand-prevention-program

Study Concludes Benefits of Anti-HIV Therapy During Pregnancy Outweigh Risks

Date: June 12, 2002

Source: National Institutes of Health (NIH)

http://aidsinfo.nih.gov/news/608/study-concludes-benefits-of-anti-hiv-therapy-during-pregnancy-outweigh-risks

Garlic Supplements Can Impede HIV Medication

Date: December 5, 2001

Source: National Institutes of Health (NIH)

Author: Warren Grant Magnusen Clinical Center

http://aidsinfo.nih.gov/news/584/garlic-supplements-can-impede-hiv-medication

7-Day-On, 7-Day-Off Regimen Could Reduce Cost, Toxicities of HIV Therapy

Date: December 3, 2001

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/582/7-day-on-7-day-off-regimen-could-reduce-cost-toxicities-of-hiv-therapy

New Finding May Help Doctors Prevent HIV Drug Resistance

Date: November 22, 2001

Source: National Institutes of Health (NIH)

http://aidsinfo.nih.gov/news/580/new-finding-may-help-doctors-prevent-hiv-drug-resistance

FDA Approves Viread for HIV-1 Infection

Date: October 29, 2001

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/576/fda-approves-viread-for-hiv-1-infection

Use of Antifungal Drug Fluconazole Effective in Preventing Thrush in Persons Who are HIV Positive

Date: April 24, 2001

Source: Agency for Healthcare Research and Quality (AHRQ)

http://aidsinfo.nih.gov/news/553/use-of-antifungal-drug-fluconazole-effective-in-preventing-thrush-in-persons-who-are-hiv-positive

FDA/Bristol Myers Squibb Issues Caution for HIV Combination Therapy with Zerit and Videx in Pregnant Women

Date: January 5, 2001

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/549/fda-bristol-myers-squibb-issues-caution-for-hiv-combination-therapy-with-zerit-and-videx-in-pregnant-women

FDA Approves Trizivir for HIV

Date: November 15, 2000

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/544/fda-approves-trizivir-for-hiv

Interleukin-2 May Help Patients With Advanced HIV Disease, New Study Shows

Date: October 25, 2000

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/542/interleukin-2-may-help-patients-with-advanced-hiv-disease-new-study-shows

Shorter AZT Treatment Reduces Mother to Child HIV Transmission As Well As Longer Treatment But For Less Cost

Date: October 4, 2000

Source: National Institutes of Health (NIH)

Author: National Institute of Child Health and Human Development (NICHD)

http://aidsinfo.nih.gov/news/541/shorter-azt-treatment-reduces-mother-to-child-hiv-transmission-as-well-as-longer-treatment-but-for-less-cost

FDA Approves Kaletra for HIV Infection

Date: September 15, 2000

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/539/fda-approves-kaletra-for-hiv-infection

Statement from Claude Lenfant, M.D., Director, National Heart, Lung, & Blood Institute, on AZT and Cardiac Damage in Infants

Date: September 13, 2000

Source: National Institutes of Health (NIH)

Author: National Heart, Blood and Lung Institute (NHLBI)

http://aidsinfo.nih.gov/news/538/statement-from-claude-lenfant-md-director-national-heart-lung--blood-institute-on-azt-and-cardiac-damage-in-infants

Inexpensive AIDS Drug Still Reduces HIV Transmission from Mother to Child After One Year

Date: July 13, 2000

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/535/inexpensive-aids-drug-still-reduces-hiv-transmission-from-mother-to-child-after-one-year

UPDATE ON CLINICAL TRIALS OF INTERLEUKIN-2 (IL-2) AS IMMUNE-BASED THERAPY FOR HIV

Date: July 8, 2000

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/531/update-on-clinical-trials-of-interleukin-2-(il-2)-as-immune-based-therapy-for-hiv

NIAID Topical Microbicide Research Developing New Tools to Protect Women from HIV/AIDS and Other STDs

Date: March 1, 2000

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/345/niaid-topical-microbicide-research-developing-new-tools-to-protect-women-from-hiv-aids-and-other-stds

NIH Clinical Center Study Demonstrates Dangerous Interaction Between St. John's Wort and an HIV Protease Inhibitor

Date: February 10, 2000

Source: National Institutes of Health (NIH)

http://aidsinfo.nih.gov/news/519/nih-clinical-center-study-demonstrates-dangerous-interaction-between-st-johns-wort-and-an-hiv-protease-inhibitor

NIAID Study: Rapid Rebound of HIV and Reappearance of HIV Reservoirs in Patients Treated with IL-2 and Combination Antiretroviral Drugs Following Cessation of Therapy

Date: October 27, 1999

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/512/niaid-study-rapid-rebound-of-hiv-and-reappearance-of-hiv-reservoirs-in-patients-treated-with-il-2-and-combination-antiretroviral-drugs-following-cessation-of-therapy

New Model Suggests That AIDS Drugs May Not Abolish HIV Infection

Date: October 6, 1999

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/511/new-model-suggests-that-aids-drugs-may-not-abolish-hiv-infection

Researchers Identify a Simple, Affordable Drug Regimen That is Highly Effective in Preventing HIV Infection in Infants of Mothers with the Disease

Date: July 14, 1999

Source: Department of Health and Human Services (DHHS)

http://aidsinfo.nih.gov/news/496/researchers-identify-a-simple-affordable-drug-regimen-that-is-highly-effective-in-preventing-hiv-infection-in-infants-of-mothers-with-the-disease

Attacking AIDS with a 'Cocktail' Therapy: Drug Combo Sends Deaths Plummeting

Date: July 1, 1999

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/493/attacking-aids-with-a-cocktail-therapy-drug-combo-sends-deaths-plummeting

Scientists Suggest New Approaches for Development of AIDS Drugs and Vaccines

Date: June 21, 1999

Source: National Institutes of Health (NIH)

Author: National Cancer Institute (NCI)

http://aidsinfo.nih.gov/news/492/scientists-suggest-new-approaches-for-development-of-aids-drugs-and-vaccines

New Anti-HIV Therapies Needed To Eradicate HIV

Date: May 26, 1999

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/489/new-anti-hiv-therapies-needed-to-eradicate-hiv

FDA Approves Amprenavir for HIV Infection

Date: April 16, 1999

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/479/fda-approves-amprenavir-for-hiv-infection

Reassuring Findings About Infants Exposed to Zidovudine

Date: January 12, 1999

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/465/reassuring-findings-about-infants-exposed-to-zidovudine

FDA Approves Abacavir for HIV-1 Infection

Date: December 18, 1998

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/463/fda-approves-abacavir-for-hiv-1-infection

Protease Inhibitors May Increase Blood Glucose in HIV Patients

Date: December 1, 1998

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/421/protease-inhibitors-may-increase-blood-glucose-in-hiv-patients

Treatment With IL-2 Plus HAART Markedly Reduces HIV in Immune System 'Hiding Places'

Date: November 15, 1998

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/451/treatment-with-il-2-plus-haart-markedly-reduces-hiv-in-immune-system-hiding-places

Information About the Safety of Combination Antiretroviral Treatment for Human Immunodeficiency Virus Infection During Pregnancy

Date: October 15, 1998

Source: Centers for Disease Control and Prevention (CDC)

http://aidsinfo.nih.gov/news/454/information-about-the-safety-of-combination-antiretroviral-treatment-for-human-immunodeficiency-virus-infection-during-pregnancy

Study Shows Efavirenz Promising in Treating Pediatric HIV Infection: Leads to Approval of New Drug for Treating HIV-infected Children

Date: September 28, 1998

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/442/study-shows-efavirenz-promising-in-treating-pediatric-hiv-infection-leads-to-approval-of-new-drug-for-treating-hiv-infected-children

Scientist Report New Strategy to Rapidly Assess Effectiveness of AIDS Drugs in Children

Date: September 22, 1998

Source: National Institutes of Health (NIH)

Author: National Cancer Institute (NCI)

http://aidsinfo.nih.gov/news/445/scientist-report-new-strategy-to-rapidly-assess-effectiveness-of-aids-drugs-in-children

FDA Approves New Drug to Treat HIV, AIDS

Date: September 18, 1998

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/443/fda-approves-new-drug-to-treat-hiv-aids

The Perils of Discontinuing Therapy: Without HAART, Cytokines Stimulate HIV From Latently Infected Cells

Date: July 6, 1998

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/426/the-perils-of-discontinuing-therapy-without-haart-cytokines-stimulate-hiv-from-latently-infected-cells

Short Course of AZT Given Late in Pregnancy and During Delivery Contributes to Reducing Mother-to-Child HIV Transmission

Date: June 29, 1998

Source: Centers for Disease Control and Prevention (CDC)

http://aidsinfo.nih.gov/news/436/short-course-of-azt-given-late-in-pregnancy-and-during-delivery-contributes-to-reducing-mother-to-child-hiv-transmission

Interleukin-12 Helps Control Mycobacterium Avium Infection

Date: June 1, 1998

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/417/interleukin-12-helps-control-mycobacterium-avium-infection

Short-Course Regimen of AZT Proven Effective in Reducing Perinatal HIV Transmission: Offers Hope for Reducing Mother-to-Child HIV Transmission in Developing World

Date: February 18, 1998

Source: Department of Health and Human Services (DHHS)

http://aidsinfo.nih.gov/news/409/short-course-regimen-of-azt-proven-effective-in-reducing-perinatal-hiv-transmission-offers-hope-for-reducing-mother-to-child-hiv-transmission-in-developing-world

Statement by Donna E. Shalala, Secretary of Health and Human Services, Regarding Findings of Thailand Study of 'Short Course' AZT.

Date: February 18, 1998

Source: Department of Health and Human Services (DHHS)

http://aidsinfo.nih.gov/news/410/statement-by-donna-e-shalala-secretary-of-health-and-human-services-regarding-findings-of-thailand-study-of-short-course-azt

Short-Course TB Prophylaxis Effective in HIV-Infected Individuals

Date: February 11, 1998

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/408/short-course-tb-prophylaxis-effective-in-hiv-infected-individuals

3-D Structure of HIV Components May Pave the Way for New Anti-AIDS Drugs

Date: January 15, 1998

Source: National Institutes of Health (NIH)

Author: National Institute of General Medical Sciences (NIGMS)

http://aidsinfo.nih.gov/news/401/3-d-structure-of-hiv-components-may-pave-the-way-for-new-anti-aids-drugs

FDA Approves New Formulation of First Protease Inhibitor Saquinavir

Date: November 7, 1997

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/393/fda-approves-new-formulation-of-first-protease-inhibitor-saquinavir

FDA Approves First Combination Drug for AIDS

Date: September 29, 1997

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/388/fda-approves-first-combination-drug-for-aids

New Side Effects of Popular AIDS Drug Reported

Date: July 14, 1997

Source: National Institutes of Health (NIH)

http://aidsinfo.nih.gov/news/379/new-side-effects-of-popular-aids-drug-reported

TB Prophylaxis Unnecessary in HIV-Infected People with Anergy, Study Suggests

Date: June 30, 1997

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/381/tb-prophylaxis-unnecessary-in-hiv-infected-people-with-anergy-study-suggests

Two Drugs Better Than One for Treating Children with Symptomatic HIV

Date: June 26, 1997

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/376/two-drugs-better-than-one-for-treating-children-with-symptomatic-hiv

Approved Therapies for HIV/AIDS or AIDS-related Conditions

Date: June 17, 1997

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/364/approved-therapies-for-hiv-aids-or-aids-related-conditions

Study Of Low-dose Oral Alpha Interferon Closes

Date: June 13, 1997

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/369/study-of-low-dose-oral-alpha-interferon-closes

Diabetes and Hyperglycemia in Patients Receiving Protease Inhibitors

Date: June 11, 1997

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/380/diabetes-and-hyperglycemia-in-patients-receiving-protease-inhibitors

Health Advisory For Newest Class Of Aids Drugs

Date: June 11, 1997

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/366/health-advisory-for-newest-class-of-aids-drugs

CDC Statement On Post-exposure Prophylaxis For Exposures To HIV

Date: June 10, 1997

Source: Centers for Disease Control and Prevention (CDC)

http://aidsinfo.nih.gov/news/367/cdc-statement-on-post-exposure-prophylaxis-for-exposures-to-hiv

CDC Studies of AZT to Prevent Mother-to-Child HIV Transmission in Developing Countries

Date: June 1, 1997

Source: Centers for Disease Control and Prevention (CDC)

http://aidsinfo.nih.gov/news/363/cdc-studies-of-azt-to-prevent-mother-to-child-hiv-transmission-in-developing-countries

Combination Drug Therapy for AIDS Found to Control Blinding Eye Infection

Date: May 20, 1997

Source: National Institutes of Health (NIH)

Author: National Eye Institute (NEI)

http://aidsinfo.nih.gov/news/357/combination-drug-therapy-for-aids-found-to-control-blinding-eye-infection

Study Shows That Doxil is Highly Effective and Safe in the Treatment of Advanced Kaposi's Sarcoma

Date: May 20, 1997

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/456/study-shows-that-doxil-is-highly-effective-and-safe-in-the-treatment-of-advanced-kaposis-sarcoma

Grapefruit Juice Study May Aid Drug Safety

Date: May 14, 1997

Source: National Institutes of Health (NIH)

Author: National Institute of General Medical Sciences (NIGMS)

http://aidsinfo.nih.gov/news/355/grapefruit-juice-study-may-aid-drug-safety

NIAID Evaluates N-9 Film as Microbicide

Date: April 3, 1997

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/344/niaid-evaluates-n-9-film-as-microbicide

IL-2 Injections Safely Boost CD4+ T Cell Levels in HIV-Infected Patients

Date: March 24, 1997

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/340/il-2-injections-safely-boost-cd4--t-cell-levels-in-hiv-infected-patients

FDA Approves First Protease Inhibitors With Labeling for Use in Children

Date: March 14, 1997

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/335/fda-approves-first-protease-inhibitors-with-labeling-for-use-in-children

FDA Proposes New Use Initiative

Date: March 13, 1997

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/336/fda-proposes-new-use-initiative

Scientists to Discuss Chemokine Receptor Research

Date: January 23, 1997

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/328/scientists-to-discuss-chemokine-receptor-research

Summary of the Meeting of a Panel to Review Studies of Transplacental Toxicity of AZT

Date: January 14, 1997

Source: National Institutes of Health (NIH)

http://aidsinfo.nih.gov/news/330/summary-of-the-meeting-of-a-panel-to-review-studies-of-transplacental-toxicity-of-azt

New ACTG 076 Analysis Emphasizes Importance of Offering AZT Therapy to All HIV-Infected Pregnant Women

Date: November 27, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/20/new-actg-076-analysis-emphasizes-importance-of-offering-azt-therapy-to-all-hiv-infected-pregnant-women

Important Information on the Combination of Zidovudine (ZDV) and Stavudine (d4T) in ZDV-experienced HIV-Infected Patients

Date: November 22, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/28/important-information-on-the-combination-of-zidovudine-(zdv)-and-stavudine-(d4t)-in-zdv-experienced-hiv-infected-patients

IL-2 Therapy Doubles CD4+ T Cell Counts in HIV-Infected People

Date: October 30, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/314/il-2-therapy-doubles-cd4--t-cell-counts-in-hiv-infected-people

Notice to Readers: Clinical Update: Impact of HIV Protease Inhibitors on the Treatment of HIV-Infected Tuberculosis Patients with Rifampin

Date: October 25, 1996

Source: Centers for Disease Control and Prevention (CDC)

http://aidsinfo.nih.gov/news/316/notice-to-readers-clinical-update-impact-of-hiv-protease-inhibitors-on-the-treatment-of-hiv-infected-tuberculosis-patients-with-rifampin

Drug Combo Safe for HIV-Infected Children

Date: September 1, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/321/drug-combo-safe-for-hiv-infected-children

Interleukin-2 Continues to Show Promise as HIV Therapy

Date: September 1, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/317/interleukin-2-continues-to-show-promise-as-hiv-therapy

Nevirapine Approved by FDA: First non-nucleoside reverse transcriptase inhibitor

Date: September 1, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/322/nevirapine-approved-by-fda-first-non-nucleoside-reverse-transcriptase-inhibitor

Volunteers Sought for HIV Treatment Study

Date: September 1, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/318/volunteers-sought-for-hiv-treatment-study

FDA Approves Drug for AIDS Wasting

Date: August 23, 1996

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/312/fda-approves-drug-for-aids-wasting

NIH-Sponsored Study Stopped: New Drug Does Not Control AIDS-Related Eye Disease

Date: August 15, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/225/nih-sponsored-study-stopped-new-drug-does-not-control-aids-related-eye-disease

TB Increases HIV Replication in HIV-Infected People

Date: August 1, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/296/tb-increases-hiv-replication-in-hiv-infected-people

Important Therapeutic Information on the Dosing of Clarithromycin for the Treatment of Disseminated Mycobacterium avium Complex (DMAC) Infection in HIV-Infected Patients

Date: July 23, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/291/important-therapeutic-information-on-the-dosing-of-clarithromycin-for-the-treatment-of-disseminated-mycobacterium-avium-complex-(dmac)-infection-in-hiv-infected-patients

Fluconazole Prevents Yeast Infections in Women with HIV

Date: July 10, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/285/fluconazole-prevents-yeast-infections-in-women-with-hiv

IL-2 Therapy: Encouraging Data on Quality of Life Reported for Immune-Boosting Drug

Date: July 10, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/286/il-2-therapy-encouraging-data-on-quality-of-life-reported-for-immune-boosting-drug

Interleukin-2 Injections Produce Dramatic, Sustained Increases in CD4+ T Cell Counts in Patients with Early-Stage HIV Disease

Date: July 10, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/288/interleukin-2-injections-produce-dramatic-sustained-increases-in-cd4--t-cell-counts-in-patients-with-early-stage-hiv-disease

NIAID Study Rules Out High-Dose Clarithromycin for AIDS-Related MAC

Date: July 10, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/287/niaid-study-rules-out-high-dose-clarithromycin-for-aids-related-mac

The Protease Inhibitors

Date: July 1, 1996

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/298/the-protease-inhibitors

FDA Approves Cidofovir for AIDS-Related Retinitis

Date: June 27, 1996

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/276/fda-approves-cidofovir-for-aids-related-retinitis

FDA Approves Nevirapine to Treat HIV

Date: June 24, 1996

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/290/fda-approves-nevirapine-to-treat-hiv

Antiretrovirals Plus Immunomodulators: Didanosine/Interferon-alpha Combination Shows Promise

Date: June 1, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/293/antiretrovirals-plus-immunomodulators-didanosine-interferon-alpha-combination-shows-promise

Expanded Access and Expedited Approval of New Therapies Related to HIV/AIDS

Date: June 1, 1996

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/269/expanded-access-and-expedited-approval-of-new-therapies-related-to-hiv-aids

An FDA Guide to Choosing Medical Treatments

Date: May 1, 1996

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/255/an-fda-guide-to-choosing-medical-treatments

Low-Dose Oral Alpha Interferon Study Opens

Date: April 1, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/240/low-dose-oral-alpha-interferon-study-opens

Two New Protease Inhibitors Approved By FDA: NIAID Research Was Pivotal to Development of New Class of Drugs

Date: April 1, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/247/two-new-protease-inhibitors-approved-by-fda-niaid-research-was-pivotal-to-development-of-new-class-of-drugs

FDA Grants Accelerated Approval To Third Protease Inhibitor To Treat HIV

Date: March 14, 1996

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/233/fda-grants-accelerated-approval-to-third-protease-inhibitor-to-treat-hiv

FDA Panel Recommends Approval of Third Protease Inhibitor

Date: March 8, 1996

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/232/fda-panel-recommends-approval-of-third-protease-inhibitor

FDA Approves Second Protease Inhibitor to Treat HIV

Date: March 1, 1996

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/231/fda-approves-second-protease-inhibitor-to-treat-hiv

Where Do HIV/AIDS Drugs Come From?

Date: February 1, 1996

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/72/where-do-hiv-aids-drugs-come-from?

Two-Drug Treatment is Effective Against Recurrent Eye Infection in AIDS Patients

Date: January 11, 1996

Source: National Institutes of Health (NIH)

Author: National Eye Institute (NEI)

http://aidsinfo.nih.gov/news/306/two-drug-treatment-is-effective-against-recurrent-eye-infection-in-aids-patients

FDA Approves First Protease Inhibitor Drug for Treatment of HIV

Date: December 7, 1995

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/215/fda-approves-first-protease-inhibitor-drug-for-treatment-of-hiv

FDA Grants Accelerated Approval for 3TC with AZT to Treat AIDS

Date: November 20, 1995

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/203/fda-grants-accelerated-approval-for-3tc-with-azt-to-treat-aids

Drug Completely Protects Monkeys Exposed to SIV

Date: November 16, 1995

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/202/drug-completely-protects-monkeys-exposed-to-siv

FDA Panel Recommends Approval of New AIDS Drug

Date: November 15, 1995

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/204/fda-panel-recommends-approval-of-new-aids-drug

FDA Panel Recommends Approval of 3TC with AZT to Treat AIDS

Date: November 7, 1995

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/201/fda-panel-recommends-approval-of-3tc-with-azt-to-treat-aids

Thalidomide Effective Treatment for AIDS-Related Mouth Ulcers

Date: October 31, 1995

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/200/thalidomide-effective-treatment-for-aids-related-mouth-ulcers

NIAID Expands Research on Topical Microbicides to Prevent STDs in Women

Date: April 27, 1995

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/186/niaid-expands-research-on-topical-microbicides-to-prevent-stds-in-women

Therapies for AIDS-Related Infections--Two Studies Published

Date: March 14, 1995

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/183/therapies-for-aids-related-infections--two-studies-published

Interleukin-2 Produces Significant, Sustained Increases in CD4+ T Cells in HIV-Infected People

Date: March 1, 1995

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/180/interleukin-2-produces-significant-sustained-increases-in-cd4--t-cells-in-hiv-infected-people

Questions and Answers about the NIAID Interleukin-2 Study

Date: March 1, 1995

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/181/questions-and-answers-about-the-niaid-interleukin-2-study

Toxoplasmosis

Date: March 1, 1995

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/139/toxoplasmosis

ARAC Reaffirms Need for Low-Dose Oral Alpha Interferon Study

Date: February 24, 1995

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/182/arac-reaffirms-need-for-low-dose-oral-alpha-interferon-study

Interim Results Lead to Discontinuation of AZT-Only Study Arm

Date: February 13, 1995

Source: Department of Health and Human Services (DHHS)

Author: Public Health Service (PHS)

http://aidsinfo.nih.gov/news/167/interim-results-lead-to-discontinuation-of-azt-only-study-arm

Oral Ganciclovir Approved

Date: December 22, 1994

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/195/oral-ganciclovir-approved

Treatment IND for AIDS-related Wasting Authorized

Date: December 21, 1994

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/194/treatment-ind-for-aids-related-wasting-authorized

NIAID Trial of Triple Drug Combination for HIV Infection Closes

Date: November 1, 1994

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/158/niaid-trial-of-triple-drug-combination-for-hiv-infection-closes

AZT Approved for Preventing Maternal-Fetal HIV Transmission

Date: August 8, 1994

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/137/azt-approved-for-preventing-maternal-fetal-hiv-transmission

Questions and Answers for Publication of 'Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus'

Date: August 5, 1994

Source: Centers for Disease Control and Prevention (CDC)

http://aidsinfo.nih.gov/news/148/questions-and-answers-for-publication-of-recommendations-of-the-us-public-health-service-task-force-on-the-use-of-zidovudine-to-reduce-perinatal-transmission-of-human-immunodeficiency-virus

Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus

Date: August 5, 1994

Source: Centers for Disease Control and Prevention (CDC)

http://aidsinfo.nih.gov/news/144/recommendations-of-the-us-public-health-service-task-force-on-the-use-of-zidovudine-to-reduce-perinatal-transmission-of-human-immunodeficiency-virus

FDA Approval of Stavudine (d4T)

Date: June 27, 1994

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/116/fda-approval-of-stavudine-(d4t)

Task Force to Study Implications of AZT in Pregnancy

Date: May 10, 1994

Source: National Institutes of Health (NIH)

http://aidsinfo.nih.gov/news/121/task-force-to-study-implications-of-azt-in-pregnancy

Effectiveness in Disease and Injury Prevention: Zidovudine for the Prevention of HIV Transmission from Mother to Infant

Date: April 29, 1994

Source: Centers for Disease Control and Prevention (CDC)

http://aidsinfo.nih.gov/news/143/effectiveness-in-disease-and-injury-prevention-zidovudine-for-the-prevention-of-hiv-transmission-from-mother-to-infant

Important Therapeutic Information on the Benefit of Zidovudine for the Prevention of the Transmission of HIV from Mother to Infant

Date: February 22, 1994

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/103/important-therapeutic-information-on-the-benefit-of-zidovudine-for-the-prevention-of-the-transmission-of-hiv-from-mother-to-infant

AZT Reduces Rate of Maternal Transmission of HIV

Date: February 21, 1994

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/99/azt-reduces-rate-of-maternal-transmission-of-hiv

FDA Licenses IGIV For Two New Indications

Date: January 3, 1994

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/268/fda-licenses-igiv-for-two-new-indications

Trimetrexate Approved For Treatment of PCP

Date: December 20, 1993

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/97/trimetrexate-approved-for-treatment-of-pcp

Fluconazole Delays Fungal Infections In AIDS Patients

Date: December 15, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/95/fluconazole-delays-fungal-infections-in-aids-patients

Primary Therapy Prevents Initial Bout of PCP

Date: December 15, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/96/primary-therapy-prevents-initial-bout-of-pcp

AIDSTRIALS and AIDSDRUGS

Date: October 1, 1993

Source: National Library of Medicine (NLM)

http://aidsinfo.nih.gov/news/309/aidstrials-and-aidsdrugs

Two Studies Examine Drugs to Prevent HIV-Associated Opportunistic Infections

Date: July 26, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/67/two-studies-examine-drugs-to-prevent-hiv-associated-opportunistic-infections

Relative Benefit of ddI and AZT Depends on Duration of Patients' Previous AZT Use

Date: June 10, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/58/relative-benefit-of-ddi-and-azt-depends-on-duration-of-patients-previous-azt-use

The Effectiveness of AZT Alone, ddC Alone or AZT/ddC Combination Is Similar Overall For Patients with Advanced HIV Disease

Date: June 10, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/59/the-effectiveness-of-azt-alone-ddc-alone-or-azt-ddc-combination-is-similar-overall-for-patients-with-advanced-hiv-disease

Trial of TAT Antagonist as Therapy for HIV Infection Altered

Date: June 10, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/57/trial-of-tat-antagonist-as-therapy-for-hiv-infection-altered

ACTG 116B/117: High Levels of AZT Resistance May Predict HIV Disease Progression

Date: June 8, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/54/actg-116b-117-high-levels-of-azt-resistance-may-predict-hiv-disease-progression

Atovaquone Effective, Well-Tolerated Treatment for AIDS-Related Pneumonia

Date: May 26, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/8/atovaquone-effective-well-tolerated-treatment-for-aids-related-pneumonia

NIAID Opens Combination Therapy Trial for HIV Infection

Date: May 25, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/7/niaid-opens-combination-therapy-trial-for-hiv-infection

Partial Results of AZT Study Reported in Lancet

Date: April 2, 1993

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/1/partial-results-of-azt-study-reported-in-lancet

NIAID Launches HIV Therapy Trial of Protease Inhibitor

Date: March 26, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/86/niaid-launches-hiv-therapy-trial-of-protease-inhibitor

NIAID Begins Study of New Drug for HIV Infection

Date: March 22, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/3/niaid-begins-study-of-new-drug-for-hiv-infection

Results of Trial of ddI in Patients Intolerant of AZT Announced

Date: February 26, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/26/results-of-trial-of-ddi-in-patients-intolerant-of-azt-announced

Clinical Alert: Important Therapeutic Information on Treatment of HIV Infection in HIV-Infected Patients Who Are Intolerant of or Have Failed Zidovudine Therapy

Date: February 1, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/40/clinical-alert-important-therapeutic-information-on-treatment-of-hiv-infection-in-hiv-infected-patients-who-are-intolerant-of-or-have-failed-zidovudine-therapy

Important Therapeutic Information on Treatment of HIV Infection in HIV-Infected Patients Who Are Intolerant of or Have Failed Zidovudine Therapy

Date: February 1, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/21/important-therapeutic-information-on-treatment-of-hiv-infection-in-hiv-infected-patients-who-are-intolerant-of-or-have-failed-zidovudine-therapy

Patients' Own Immune Cells Used in Experimental HIV Therapy

Date: January 4, 1993

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/85/patients-own-immune-cells-used-in-experimental-hiv-therapy

FDA Approves New Indication For Dronabinol

Date: December 23, 1992

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/12/fda-approves-new-indication-for-dronabinol

Rifabutin Approval

Date: December 23, 1992

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/13/rifabutin-approval

TMP/SMX Better than Aerosolized Pentamidine for Preventing Recurrent PCP

Date: December 23, 1992

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/88/tmp-smx-better-than-aerosolized-pentamidine-for-preventing-recurrent-pcp

Multi-Site Trial Begins of the Anti-AIDS Drug, Tat Antagonist

Date: November 30, 1992

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/46/multi-site-trial-begins-of-the-anti-aids-drug-tat-antagonist

Atovaquone Receives Approval for Treatment of PCP

Date: November 27, 1992

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/10/atovaquone-receives-approval-for-treatment-of-pcp

First AIDS Drug Tested Under Parallel Track Policy; other d4T related press releases

Date: October 5, 1992

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/93/first-aids-drug-tested-under-parallel-track-policy;-other-d4t-related-press-releases

ddI Receives Additional Approval

Date: October 1, 1992

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/11/ddi-receives-additional-approval

Switch To ddI From AZT Appears to Slow Progression of HIV Disease

Date: August 26, 1992

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/18/switch-to-ddi-from-azt-appears-to-slow-progression-of-hiv-disease

Approval of Zalcitabine

Date: June 22, 1992

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/29/approval-of-zalcitabine

Advisory Committee Recommends Approval of ddC as Combination AIDS Therapy

Date: April 21, 1992

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/32/advisory-committee-recommends-approval-of-ddc-as-combination-aids-therapy

Early Use of AZT Reduces Risk of Death

Date: April 15, 1992

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/16/early-use-of-azt-reduces-risk-of-death

Summary of Preliminary Analysis of Study Comparing ddI and ZDV

Date: April 13, 1992

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/45/summary-of-preliminary-analysis-of-study-comparing-ddi-and-zdv

Study Shows Promise of Fluconazole for Treatment of AIDS-Related Cryptococcal Meningitis

Date: January 8, 1992

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/43/study-shows-promise-of-fluconazole-for-treatment-of-aids-related-cryptococcal-meningitis

ACTG 106: AZT/ddC Combination Shows Benefits for Patients with Advanced HIV Disease

Date: December 31, 1991

Source: National Institutes of Health (NIH)

Author: National Institute of Allergy and Infectious Diseases (NIAID)

http://aidsinfo.nih.gov/news/42/actg-106-azt-ddc-combination-shows-benefits-for-patients-with-advanced-hiv-disease

Atovaquone (566C80) Receives Treatment IND Status for AIDS Related Use

Date: November 12, 1991

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/31/atovaquone-(566c80)-receives-treatment-ind-status-for-aids-related-use

HHS Secretary Louis W. Sullivan announces FDA's approval of ddI.

Date: October 9, 1991

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/35/hhs-secretary-louis-w-sullivan-announces-fdas-approval-of-ddi

Epoetin Alfa For AIDS Related Condition

Date: January 2, 1991

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/221/epoetin-alfa-for-aids-related-condition

AZT for Children

Date: May 3, 1990

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/271/azt-for-children

Expanded Labeling for AZT

Date: March 2, 1990

Source: Food and Drug Administration (FDA)

http://aidsinfo.nih.gov/news/272/expanded-labeling-for-azt

Approval of AZT

Date: March 20, 1987

Source: Department of Health and Human Services (DHHS)

Author: Public Health Service (PHS)

http://aidsinfo.nih.gov/news/274/approval-of-azt
Back to Top